Literature DB >> 25037792

Vismodegib-associated hepatotoxicity: a potential side effect detected in postmarketing surveillance.

Daniel J Ventarola1, David I Silverstein2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25037792     DOI： 10.1016/j.jaad.2014.04.023

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Vismodegib and risk of cholestatic injury: should we screen candidate patients?

Authors:  Michelangelo Vestita; Lucia Lospalluti; Giuseppe Giudice; Domenico Bonamonte; Ignazio Rossiello; Angela Filoni
Journal:  Clin Exp Med       Date:  2016-08-02       Impact factor: 3.984

2.  Hepatotoxicity Associated With Vismodegib.

Authors:  Prabhjot S Bedi; Manoj P Rai; Nishant Tageja; Heather Laird-Fick
Journal:  BMJ Case Rep       Date:  2018-02-08

Review 3.  Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer.

Authors:  Richard L Carpenter; Haimanti Ray
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

4.  Hepatotoxicity with Vismodegib: An MD Anderson Cancer Center and Research on Adverse Drug Events and Reports Project.

Authors:  Beatrice J Edwards; Dennis W Raisch; Smita S Saraykar; Ming Sun; Josh A Hammel; Hai T Tran; Nathaniel Wehr; Rasha Arabyat; Dennis P West
Journal:  Drugs R D       Date:  2017-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.